Skip to main content
. 2010 Nov 30;5(11):e14130. doi: 10.1371/journal.pone.0014130

Figure 3. Immunohistochemical analysis of Ep-ICD expression in prostate and colon cancers.

Figure 3

Membrane, cytoplasmic, and nuclear Ep-ICD expression in prostate cancer (A) and colon cancer (B). Some areas of the tissue section show predominant membrane and weak cytoplasmic but no nuclear localization of Ep-ICD (A, B - left square), while the other areas of the same tissue section show nuclear and cytoplasmic accumulation of Ep-ICD with absence of membranous Ep-ICD expression (A, B - right square). Original magnification ×400.